Abstract
This study was designed to investigate the physical characteristics and crystalline structure of 2-hydroxy-N-[3(5)-pyrazolyl]-1,4-naphthoquinone-4-imine (PNQ), a new active compound againstTrypanosoma cruzi, the causative agent of American trypanosomiasis. Methods used included differential scanning calorimetry, thermogravimetry, hot stage microscopy, polarized light microscopy (PLM), Fourier-transform infrared (FTIR) spectroscopy, and high-resolution X-ray powder diffraction (HR-XRPD). According to PLM and HR-XRPD data, PNQ crystallized as red oolitic crystals (absolute methanol) or prisms (dimethyl sulfoxide [DMSO]-water) with the same internal structure. The findings obtained with HR-XRPD data (applying molecular location methods) showed a monoclinic unit cell [a=18.4437(1)Å, b=3.9968(2) Å, c=14.5304(1) Å, α=90°, β=102.71(6)°, γ=90°, V=1044.9(1) Å3, Z=4, space group P21/c], and a crystal structure (excluding H-positions) described by parallel layers in the direction of theb-axis, with molecules held by homochemical (phenyl-phenyl and pyrazole-pyrazole) van der Waals interactions. In addition, FTIR spectra displayed the NH-pyrazole stretch overlapped with the OH absorption at 3222 cm−1, typical of-NH and-OH groups associated through H-bondings; and a carbonyl stretching absorption at 1694 cm−1, indicating a non-extensively H-bonded quinonic C=O, which was in accordance with the solved crystal structure of PNQ. The existence of such cohesive forces shed light on the thermo-analytical data, which revealed that PNQ is a stable solid, unaffected by oxygen that decomposed without melting above 260°C.
Similar content being viewed by others
References
Figueroa JP. Report of the Workgroup on parasitic diseases.Morb Mortal Wkly Rep. 1999;48:118–125.
Ferreira RCC, Ferreira LCS. Mutagenicity of nifurtimox and benznidazole in the salmonella/microsome assay.Braz J Med Biol Res. 1986;19:19–25.
Radloff PD, Philips J, Nkeyi M, Hutchinson D, Krensner PG. Atovaquone and proguanil forplasmodium falciparum malaria.Lancet. 1996;347:1511–1514.
Li CJ, Li YZ, Pinto AV, Pardee AB. Potent inhibition of tumor survival in vivo by β-lapachone plus taxol: combining drugs imposes different artificial checkpoints.Proc Natl Acad Sci USA. 1999;96:13369–13374.
Sperandeo NR, Brun R. Synthesis and biological evaluation of pyrazolylnaphthoquinones as new potential antiprotozoal and cytotoxic agents.Chem Bio Chem. 2003;4:69–72.
Byrn SR, Pfeifer R, Stowell JF.Solid-State Chemistry of Drugs. 2nd ed. West Lafayette, IN: SSCI Inc; 1999.
Wells J.Pharmaceutical Preformulation: The Physicochemical Properties of Drug Substances. New York, NY: Ellis Horwood Ltd, John Wiley & Sons; 1993.
Britain HG.Physical Characterization of Pharmaceutical Solids Vol 70. New York, NY: Marcel Dekker Inc; 1995.
Pagola S, Stephens PW, Bohle DS, Kosar AD, Madsen SK. The structure of malaria pigment β-haematin.Nature. 2000;404:307–310.
Spek AL.PLATON, A Multipurpose Crystallographic Tool. 2001. Utrecht, The Netherlands: Utrecht University. Available at: http://www. cryst.chem.uu.nl/platon/. Accessed: July 8, 2005.
Ghosh S, Ojala WH, Gleason WB, Grant DJW. Relationships between crystal structures, thermal properties and solvate stability of dialkylhydroxypyridones and their formic acid solvates.J Pharm Sci. 1995;84:1392–1399.
United States Pharmacopeial Convention.United States Pharmacopeia XXVI. Washington, DC: United States Pharmacopeial Convention Inc. 2003.
Dinnebier RE. GUFI Powder Diffraction Software. 2002. Available at: http://www.fkf.mpg.de/xray/html/body_gufi_software.html. Accessed: July 8, 2005.
Visser JW. A fully automatic program for finding the unit cell from powder data.J Appl Cryst [serial online]. 1969. Available at: http://sdpd.univ-lemans.fr/ftp/itol3.zip. Accessed: July 8, 2005.
Le Bail A, Duroy H, Fourquet JL. Ab-initio structure determination of LiSbWO6 by X-ray powder diffraction.Mat Res Bull. 1988; 23:447–452.
Rodriguez-Carvajal J. FULLPROF: A program for Rietveld refinement and pattern matching analysis.Abstracts of the Satellite Meeting on Powder Diffraction of the XV Congress of the IUCr. 1990. Toulouse, France. Available at: http://www-llb.cea.fr/fullweb.powder.htm. Accessed: July 8, 2005.
Larson AC, Von Dreele RB.GSAS, Generalized Crystal Structure Analysis System. 1987. Los Alamos, NM: Los Alamos National Laboratory Report Number LA-UR-86-748. Available at: http://www.ccp14.ac.uk/ccp/ccp 14/ftp-mirror/gsas/public/gsas/. Accessed: July 8, 2005.
Stephens PW, Pagola S. Powder Structure Solution Program [computer program]. Version 2000. Available at: http://powder.physics. sunysb.edu/programPSSP/pssp.html. Accessed: July 8, 2005.
Allen FH, Kennard O. 3D search and research using the Cambridge structural database.Chem Design Automation News. 1998;8:31–37.
Farrugia LJ, Program Ortep-3 for Windows.J Appl Cryst [serial online]. 1997. Available at: http://www.chem.gla.ac.uk/∼louis/software/. Accessed: July 8, 2005.
Scott HG. The estimation of standard deviation in powder diffraction Rietveld refinements.J Appl Crystallogr. 1983;16:159–163.
Focés-Focés C, Llamas-Saiz AL, Claramunt RM, López C, Elguero JJ. Structure of 3(5)-methyl-4-nitropyrazole in the solid state: tautomerism, crystallography and the problem of desmotropy.J Chem Soc Chem Commun. 1994:1143–1145.
Fernández AE, de Bertorello MM, Manzo RH. Síntesis y propiedades espectroscópicas de aminoisoxazolilnaftoquinonas.Anales Asoc Quím Argent. 1982;70:49–60.
Sperandeo NR, de Bertorello MM, Briñón MC. Synthesis and some physicochemical properties of 2-hydroxy-N-(3,4-dimethyl-5-isoxazolyl)-1,4-naphthoquinone-4-imine derivatives.J Pharm Sci. 1994;83:332–335.
Dorn H, Zubek A. Bicyclische systeme aus acetessigester und 5-amino-1-methyl-5-amno-1-benzyl-sowie 3(5)-aminopyrazol.Chem Ber. 1968;101:3265–3277.
Galwey AK. Thermal reaction of selected solids including reactants that melt during chemical change.J Thermal Anal. 1994;41:267–286.
Sperandeo NR, de Bertorello MM. Solid state characterization of new protozoocidal agents—aminoisoxazolylnaphthoquinones.Thermochim Acta. 2001;378:69–77.
Ford JL, Timmins P.Pharmaceutical Thermal Analysis: Techniques and Applications. New York, NY: Ellis Horwood Ltd, John Wiley & Sons; 1989.
Berbenni V, Marini A, Bruni G, Maggioni A, Riccardi R, Orlandi A. Physico-chemical characterization of different solid forms of spironolactona.Thermochim Acta. 1999;340–341:117–129.
Marel Van Der HW. Quantitative differential thermal analysis of clay mineral and other minerals.Am Mineral. 1956;41:222–224.
MacKenzie RC, Michell BD. Differential thermal analysis data: a review.Analyst. 1962;87:420–434.
Haleblian JK. Characterization of habits and crystalline modification of solids and their pharmaceutical applications.J Pharm Sci. 1975;64:1269–1288.
Tiwary AK, Panpalia GM. Influence of crystal habit on trimethoprim suspension formulation.Pharm Res. 1999;16:261–265.
Dresse A, Gegard MA, Lays A. Human pharmacokinetics of 2 crystalline and galenic forms of diflunisal, a new analgesic.Pharm Acta Helv. 1978;53:177–181.
Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.Pharm Res. 1995;12:413–420.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published: December 27, 2005
Rights and permissions
About this article
Cite this article
Sperandeo, N.R., Karlsson, A., Cuffini, S. et al. The crystal structure and physicochemical characteristics of 2-hydroxy-N-[3(5)-pyrazolyl]-1,4-naphthoquinone-4-imine, a new antitrypanosomal compound. AAPS PharmSciTech 6, 82 (2005). https://doi.org/10.1208/pt060482
Received:
Revised:
Accepted:
DOI: https://doi.org/10.1208/pt060482